Wayne State University-Karmanos Cancer Institute — Detroit, Michigan

Wayne State University-Karmanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Wayne State University-Karmanos Cancer Institute has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6).

Sponsors: Children's Oncology Group, University of Michigan, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wayne State University-Karmanos Cancer Institute?

Wayne State University-Karmanos Cancer Institute has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wayne State University-Karmanos Cancer Institute conducted?

Wayne State University-Karmanos Cancer Institute has 6 clinical trials on record, with 1 currently active. Their work covers Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6).

Is Wayne State University-Karmanos Cancer Institute accredited by Crixeo Health?

Yes — Wayne State University-Karmanos Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Wayne State University-Karmanos Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.